Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Contract Development Services, Small Molecules, Contract Manufacturing Services

Embracing Technologies & Enhancing Outcomes

sponsored by Johnson Matthey

Experts from Johnson Matthey examine some of the hottest trends in drug development. With many new drugs suffering from poor solubility and bioavailability, Alan Chorlton discusses why solid state science is more important than ever before, while Paul Evans examines the innovator drugs today that will be tomorrow’s generic targets. Looking to the medicines of the future, Beatriz Dominguez and Ahir Pushpanath explain how enzyme engineering has opened up new possibilities in biocatalysis, and Kevin Hennessy looks at the growing interest in cannabinoid drug development. Finally, Nick Shackley gives his view on why outsourcing can help companies get the most from their molecules.

>> Download the PDF

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login as a Guest or via Social Media

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register